Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Change in Taxes: 2022-2024

Historic Change in Taxes for Gyre Therapeutics (GYRE) over the last 3 years, with Dec 2024 value amounting to -$2.2 million.

  • Gyre Therapeutics' Change in Taxes rose 187.10% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$152,000, marking a year-over-year increase of 93.71%. This contributed to the annual value of -$2.2 million for FY2024, which is 172.13% down from last year.
  • Gyre Therapeutics' Change in Taxes amounted to -$2.2 million in FY2024, which was down 172.13% from $3.0 million recorded in FY2023.
  • In the past 5 years, Gyre Therapeutics' Change in Taxes ranged from a high of $3.0 million in FY2023 and a low of -$2.2 million during FY2024.
  • For the 3-year period, Gyre Therapeutics' Change in Taxes averaged around -$169,000, with its median value being -$1.3 million (2022).
  • In the last 5 years, Gyre Therapeutics' Change in Taxes surged by 323.44% in 2023 and then plummeted by 172.13% in 2024.
  • Yearly analysis of 3 years shows Gyre Therapeutics' Change in Taxes stood at -$1.3 million in 2022, then spiked by 323.44% to $3.0 million in 2023, then slumped by 172.13% to -$2.2 million in 2024.